Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | RET | P07949 | 1/20 | 0.43 |
| ▸ | KIF5B | P33176 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.43 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.43 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | MBD2 | Q9UBB5 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30843232 | 1.00 | TLR4 (0.50) | TLR4TLR2MGLLGRM5FFAR4 | |
| SCHEMBL29612417 | 0.87 | TLR4 (0.56) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL12129555 | 0.87 | TLR4 (0.56) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL15602369 | 0.85 | TLR4 (0.55) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL5686998 | 0.83 | SCN7A (0.47) | TLR4TLR2MGLLKDM4EPPARG | |
| SCHEMBL15387423 | 0.82 | HRH3 (0.44) | TLR4TLR2MGLLGRM5FFAR4 | |
| SCHEMBL3334396 | 0.82 | ESR2 (0.53) | TLR4TLR2MGLLGRM5MAP4K4 | |
| SCHEMBL5109000 | 0.81 | MAP4K4 (0.57) | TLR4TLR2GRM5FFAR4MAP4K4 | |
| SCHEMBL12168388 | 0.81 | F2 (0.53) | KDM4ERETKIF5BKDRRAB9A | |
| SCHEMBL6091732 | 0.81 | CHRNB2 (0.51) | MGLLAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-55108851-A | — | — | None | — | — | JP | disclosed |
| US-20260035398-A1 | TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES | UNIV ARIZONA STATE (US) | 2026-02-05 | — | — | US | disclosed |
| US-12457894-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-10-28 | — | — | US | disclosed |
| US-12312366-B2 | Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-05-27 | — | — | US | disclosed |
| EP-4185858-B1 | COMPOSITIONS, SYSTEMS AND METHODS FOR BIOLOGICAL ANALYSIS USING DYES | LIFE TECHNOLOGIES CORP (US) | 2025-05-21 | — | — | EP | disclosed |
| US-11998538-B2 | Piperidine urea derivatives as soluble epoxide hydrolase inhibitors | NEUROPN THERAPEUTICS (US) | 2024-06-04 | — | — | US | disclosed |
| US-11998538-B2 | Piperidine urea derivatives as soluble epoxide hydrolase inhibitors | NEUROPN THERAPEUTICS (US) | 2024-06-04 | — | — | US | disclosed |
| CN-110272456-B | Organometallic compound and organic light emitting device including the same | 三星显示有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20240060117-A1 | ENERGY TRANSFER DYE CONJUGATES FOR USE IN BIOLOGICAL ASSAYS | Life Technologies Corporation | 2024-02-22 | — | — | US | disclosed |
| EP-4306521-A1 | CENTRAL CHIRALITY INDUCED SPIRO CHIRAL TETRADENTATE CYCLOMETALATED PLATINUM (II) AND PALLADIUM (II) COMPLEX-BASED CIRCULARLY POLARIZED LUMINESCENCE MATERIAL AND APPLICATION THEREOF | Zhejiang University of Technology (CN) | 2024-01-17 | — | — | EP | disclosed |
| WO-2011137431-A2 | SYNTHESIS OF FOUR COORDINATED GOLD COMPLEXES AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES THEREOF | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011137431-A2 | SYNTHESIS OF FOUR COORDINATED GOLD COMPLEXES AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES THEREOF | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011137429-A2 | SYNTHESIS OF FOUR COORDINATED PALLADIUM COMPLEXES AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES THEREOF | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011137429-A2 | SYNTHESIS OF FOUR COORDINATED PALLADIUM COMPLEXES AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES THEREOF | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2010118026-A2 | SYNTHESIS OF FOUR COORDINATED PLATINUM COMPLEXES AND THEIR APPLICATIONS IN LIGHT EMITTING DEVICES THEREOF | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2010-10-14 | — | — | WO | disclosed |
| US-7781074-B2 | Organic electroluminescent element | FUJIFILM CORPORATION (JP) | 2010-08-24 | — | — | US | disclosed |
| US-7781074-B2 | Organic electroluminescent element | FUJIFILM CORPORATION (JP) | 2010-08-24 | — | — | US | disclosed |
| US-4455427-A | THROMBOXANE INHIBITORS | THE UPJOHN COMPANY (US) | 1984-06-19 | — | — | US | disclosed |
| EP-0069521-A2 | Pyridinyl and imidazolyl derivatives of benzofurans and benzothiophenes | THE UPJOHN COMPANY (US) | 1983-01-12 | — | — | EP | disclosed |
| JP-S55108851-A | DERIVATIVE OF CARBAMIC ACID ESTER | MITSUI TOATSU CHEM INC | 1980-08-21 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035398-A1 | TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES | LBR, SCO2, RAD54L | TLR4 2997/4885TLR2 3466/4885MGLL 1684/4885 |
| US-12457894-B2 | Organometallic compound and organic light-emitting device including the same | CRY1, OCIAD1, ORC3 | TLR4 4148/4885TLR2 4110/4885MGLL 1473/4885 |
| US-12312366-B2 | Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues | PAICS, DNTT, PNPO | TLR4 3043/4885TLR2 4185/4885MGLL 3447/4885 |
| US-11998538-B2 | Piperidine urea derivatives as soluble epoxide hydrolase inhibitors | EPHX1, EPHX2, HPGDS | TLR4 4240/4885TLR2 4714/4885MGLL 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.